136 filings
Page 3 of 7
DEFA14A
hqz3q0b
5 Jun 23
Additional proxy soliciting materials
4:02pm
8-K
abd22h7og
11 May 23
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2023 Financial Results
7:31am
DEFA14A
u95zj33sl0hs7pr4hlfm
28 Apr 23
Additional proxy soliciting materials
4:14pm
8-K
xmg1kr
17 Apr 23
Regulation FD Disclosure
8:41am
8-K
f2ggse2y
21 Mar 23
Departure of Directors or Certain Officers
5:28pm
8-K
mo053i vf
10 Mar 23
Regulation FD Disclosure
5:26pm
8-K
50i6b
3 Mar 23
ULIXACALTAMIDE (PRAX-944) ESSENTIAL1 ESSENTIAL TREMOR TOPLINE RESULTS March 2023
7:36am
EFFECT
zo4 gbstos6nsrjyifh
10 Feb 23
Notice of effectiveness
12:15am
S-8
fnezw3
7 Feb 23
Registration of securities for employees
9:04am
POS AM
7dj wximtu
7 Feb 23
Prospectus update (post-effective amendment)
9:01am
8-K
eea00 n7yaso
7 Feb 23
Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
8:08am
POSASR
uwnxin5t
7 Feb 23
Automatic shelf registration (post-effective amendment)
8:04am
8-K
3ueelp
28 Nov 22
Regulation FD Disclosure
8:04am
8-K
npef8cxpyp9
9 Nov 22
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2022 Financial Results
4:03pm
8-K
2r9np4q s6
7 Sep 22
Other Events
7:33am
8-K
n2oxbxz
12 Aug 22
Departure of Directors or Certain Officers
4:31pm